Table 1. Socio-clinical characteristics of the HF patients studied.

Characteristic (variable)	Statistics
Gender:
Female	46.7% (222)
Male	53.3% (253)
Age (years):
M ± SD	69.7 ± 7.7
Me [Q1; Q3]	68 [64; 73]
Living alone	43.6% (206)
Professionally active	4.6% (22)
Duration of the illness (years):
M ± SD	6.2 ± 4.9
Me [Q1; Q3]	5 [3; 8]
NYHA class:
II	62.8% (298)
III	28.3% (135)
IV	8.8 (42)
EF:
M ± SD	48.6 ± 12.6
Me [Q1; Q3]	50 [40; 60]
Number of hospitalizations:
M ± SD	2.0 ± 1.5
Me [Q1; Q3]	1 [1; 3]
Number of comorbidities:
M ± SD	1.8 ± 1.2
Me [Q1; Q3]	1 [1; 2]
Medication:
Diuretics/aldosterone receptor antagonists	80.8% (384)
β-blockers	68.2% (324)
ACE inhibitors/angiotensin receptor blockers (ARBs)	85.5% (406)